---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-26-000200"
form_type: "8-K"
ticker: "KRMD"
cik: "0000704440"
company_name: "KORU Medical Systems, Inc."
filed_at: "2026-08-14T20:01:58+00:00"
generated_at: "2026-08-14T20:05:06.991701+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# KORU Medical amends bylaws to give shareholders exclusive director-removal authority

## Summary
- Board unanimously adopted Amendment No. 1 to Section 3.05 of Amended and Restated By-laws effective August 13, 2026.
- Amendment vests director removal exclusively in affirmative vote of shareholders holding a majority of outstanding shares, per Delaware law.
- Board states it has not voted, and has no intention or agreement, to remove any director.
- Amendment filed as Exhibit 3.1; no financial or operational impact disclosed.

## SEC filing metadata
- accession: 0001161697-26-000200
- form_type: 8-K
- ticker: KRMD
- cik: 0000704440
- company_name: KORU Medical Systems, Inc.
- filed_at: 2026-08-14T20:01:58+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/704440/000116169726000200/0001161697-26-000200-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/704440/000116169726000200/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-26-000200
- JSON: https://secwatch.observer/filing/0001161697-26-000200.json
- Plain text: https://secwatch.observer/filing/0001161697-26-000200.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.